Rockwell Medical, Inc.
RMTI
$0.95
$0.00-0.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.90% | -15.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.90% | -15.03% | |||
| Cost of Revenue | 0.64% | -14.52% | |||
| Gross Profit | -9.23% | -17.72% | |||
| SG&A Expenses | 0.10% | -12.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.52% | -14.08% | |||
| Operating Income | -17.42% | 0.81% | |||
| Income Before Tax | -17.49% | 1.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.49% | 1.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.49% | 1.52% | |||
| EBIT | -17.42% | 0.81% | |||
| EBITDA | -32.32% | 4.26% | |||
| EPS Basic | -1.67% | -7.88% | |||
| Normalized Basic EPS | -11.31% | 1.74% | |||
| EPS Diluted | 0.00% | -12.61% | |||
| Normalized Diluted EPS | -11.31% | 1.74% | |||
| Average Basic Shares Outstanding | 4.99% | 0.60% | |||
| Average Diluted Shares Outstanding | 4.99% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||